Compare PALI & ZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PALI | ZH |
|---|---|---|
| Founded | 1996 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 311.8M | 293.3M |
| IPO Year | N/A | 2021 |
| Metric | PALI | ZH |
|---|---|---|
| Price | $2.49 | $3.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $17.67 | N/A |
| AVG Volume (30 Days) | ★ 5.8M | 327.9K |
| Earning Date | 11-10-2025 | 11-25-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.17 |
| Revenue | N/A | ★ $416,437,241.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $19.78 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.53 | $3.19 |
| 52 Week High | $2.64 | $6.32 |
| Indicator | PALI | ZH |
|---|---|---|
| Relative Strength Index (RSI) | 65.10 | 44.79 |
| Support Level | $2.24 | $3.24 |
| Resistance Level | $2.64 | $3.42 |
| Average True Range (ATR) | 0.18 | 0.12 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 89.39 | 52.17 |
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Zhihu Inc is predominantly engaged in the operation of one online content community and monetizes through paid membership services, advertising services, content-commerce solutions services, and vocational training in China. It generates revenues from Advertising services, Paid membership services, Content-commerce solutions, and Others. It derives all its revenues within China.